You must log in to view this page.

Eton Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ETON
Share price (10/6/26): $54.77
Market cap (10/6/26): $1.565 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Ownership Filter

News Filter

Announces U.S. Commercial Availability of IMPAVIDO® (Miltefosine) Capsules

Reports Second Quarter 2026 Financial Results

Expands Infantile Hemangioma Franchise With Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

Change in Directors, Officers or Compensation

Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (Hydrocortisone) Oral Solution

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC